Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …

Male breast cancer (MBC) is a rare entity, underrepresented in population studies and
clinical trials, resulting in management of MBC to be informed by current research on female …

Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

549 Background: Because male breast cancer (BC) is rare, there is little known about the
disease and treatment is extrapolated from female BC. Newer molecular technologies have …

Purpose Male breast cancer (MBC) is a rare cancer entity, with mutations in BRCA1 and
BRCA2 genes accounting for~ 10% of patients. Multiple-gene sequencing has already …

Background: Male breast cancer (MBC) is still poorly understood with a large proportion
arising in families with a history of breast cancer. Genomic studies have focused on germline …

Background and study design Male breast cancer (MBC) is a rare disease compared with
female BC and our current understanding regarding breast carcinogenesis in men has been …

Male breast cancer (MBC) is a poorly characterized disease because of its rarity. Clinical
management is based on results obtained from randomized trials conducted in women …

Male breast cancer is a rare disease, of which little is known. In contrast to female breast
cancer, the very vast majority of all cases are positive for estrogen receptor alpha (ERα) …

Male breast cancer is a rare disease, accounting for only 1% of breast cancer diagnoses in
the USA. The current literature suggests that genetic factors including BRCA2 mutations …